R-Biopharm´s new corporate division for Complementary Diagnostics for Personalized Healthcare intensifies partnerships with pharmaceutical and biotech companies.
In driving Complementary Diagnostics, R-Biopharm is at the forefront of current advancements in testing and therapeutics development. By providing laboratory services, R-Biopharm can develop, co-develop and support new pharmaceutical development approaches, offering services precisely tailored to each project.
By converging in vitro diagnostics and therapeutics, Complementary Diagnostics takes the concept of Companion Diagnostics to new therapeutic arenas, providing the overarching research capabilities for new approaches to personalized healthcare.
The range of R-Biopharm services in terms of Complementary Diagnostics covers the entire chain of requirements, from custom assay development and laboratory services via validation & registration and manufacturing all the way to commercialization and project management.
With this scope of services, R-Biopharm is fully prepared to also undertake co-development programs for Companion Diagnostics with pharmaceutical and biotech companies.
For more information, please visit www.companion-diagnostics.com